Home > Boards > US Listed > Biotechs > MultiCell Technologies (MCET)

Multicell Immunotherapeutics, Inc.: 75000 shares Selling Stockholder of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
TPX Member Profile
Member Level 
Followed By 540
Posts 35,772
Boards Moderated 6
Alias Born 10/24/13
160x600 placeholder
TPX Member Level  Saturday, 09/22/18 08:41:19 AM
Re: MyDogBuster post# 43214
Post # of 43268 
Multicell Immunotherapeutics, Inc.: 75000 shares Selling Stockholder of GTBP Gt Biopharma Inc.

The date of this prospectus supplement is September 21, 2018.

Settlement Agreement

On September 8, 2018, we entered into a Confidential Settlement Agreement and Release, or the Settlement Agreement, with Multicell Immunotherapeutics, Inc., or Multicell, to settle a breach of contract lawsuit. As part of the Settlement Agreement, we agreed to issue to Multicell 75,000 shares of Common Stock at an agreed value of $2.00 per share. Multicell is a selling stockholder. For purposes of the table below, beneficial ownership is based on the securities held of record by the selling stockholders as of May 11, 2018.


https://ir.gtbiopharma.com/all-sec-filings/content/0001654954-18-010380/0001654954-18-010380.pdf

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist